USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Medical Imaging Industry Quarterly Tracker, Q1 2019
Global Medical Imaging Industry Quarterly Tracker, Q1 2019 Updated Research Available
Quarterly Edition of Trends in Medical Imaging and Informatics Covering Competition, Policy, Regulatory, and Clinical Areas
25-Sep-2019
North America
Market Research
$3,000.00
Special Price $2,250.00 save 25 %
Description
The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors’ business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain techniques in imaging is influencing changes in the standard of care. On a macro level, the government's policies on reimbursement and regulations tend to impact the performance of industry participants, if their internal teams delay the calibration of the strategic actions needed to thrive in this new environment.
To help its clients address challenges in an intensely competitive environment, Frost & Sullivan has introduced the Medical Imaging and Informatics Quarterly Insights tracker that will monitor market factors and significant events and qualitatively assess their impact on the industry; this will cover the diagnostic imaging, image-guided therapies, and imaging informatics segments.
Research Scope
The scope of this deliverable covers the following segments:
- Clinical Trends
o Disruptive trends that impact the current ‘gold standard’
o Trends that indicate the clinical adoption of new solutions/products
o Important announcements from associations such as RSNA, ESR, ACR, and ACC
- Competition
o New product launches and capabilities
o Mergers and acquisitions
o FDA and CE approvals
o Major FDA and CE recalls/warnings
- Policies and Regulations
o Region-specific introduction of new regulatory approvals
o Reimbursement achievements or setbacks
- Event Highlights
o Major event highlights in the quarter that cover important themes – this is derived by studying the messaging and communications, product launches, and product promotions at the events
Author: Suresh Kuppuswamy
Table of Contents
Methodology
Scope
Key Takeaways
Competition—Long-term Business Contracts
Competition—Long-term Business Contracts (continued)
Competition—Long-term Business Contracts (continued)
Competition—New Launches
Competition—New Launches (continued)
Competition—New Launches (continued)
Competition—Corporate Highlights
Competition—Corporate Highlights (continued)
Competition—Business Collaboration
FDA Approvals from Top-tier Companies (January–March 2019)
FDA Approvals from Other Companies (January–March 2019)
Notable CE Approvals
FDA Recalls
FDA Recalls (continued)
Policies and Regulations
Policies and Regulations (continued)
Policies and Regulations (continued)
Policies and Regulations (continued)
Policies and Regulations (continued)
Policies and Regulations (continued)
Policies and Regulations (continued)
Clinical Trends
Clinical Trends (continued)
Clinical Trends (continued)
Clinical Trends (continued)
Clinical Trends (continued)
Clinical Trends (continued)
Clinical Trends (continued)
Event Highlights
Event Highlights (continued)
Event Highlights (continued)
Conclusion
Legal Disclaimer
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Popular Topics
Research Scope
The scope of this deliverable covers the following segments:
- Clinical Trends
o Disruptive trends that impact the current ‘gold standard’
o Trends that indicate the clinical adoption of new solutions/products
o Important announcements from associations such as RSNA, ESR, ACR, and ACC
- Competition
o New product launches and capabilities
o Mergers and acquisitions
o FDA and CE approvals
o Major FDA and CE recalls/warnings
- Policies and Regulations
o Region-specific introduction of new regulatory approvals
o Reimbursement achievements or setbacks
- Event Highlights
o Major event highlights in the quarter that cover important themes – this is derived by studying the messaging and communications, product launches, and product promotions at the events
Author: Suresh Kuppuswamy
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Suresh Kuppuswamy |
| Industries | Healthcare |
| WIP Number | MEDA-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9566-B1,9570-B1,99BE-B1,9614-B1 |